Joshua Glover

665 total citations · 1 hit paper
7 papers, 473 citations indexed

About

Joshua Glover is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Joshua Glover has authored 7 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Oncology and 3 papers in Hematology. Recurrent topics in Joshua Glover's work include Virus-based gene therapy research (3 papers), CAR-T cell therapy research (3 papers) and Immune Cell Function and Interaction (3 papers). Joshua Glover is often cited by papers focused on Virus-based gene therapy research (3 papers), CAR-T cell therapy research (3 papers) and Immune Cell Function and Interaction (3 papers). Joshua Glover collaborates with scholars based in United States. Joshua Glover's co-authors include Anthony Secreto, Xiaochuan Shan, Ronald G. Collman, Farida Shaheen, Yanjie Yi, Gwenn Danet-Desnoyers, Houping Ni, Hiromi Muramatsu, Drew Weissman and Ying K. Tam and has published in prestigious journals such as Nature Communications, Blood and PLoS Pathogens.

In The Last Decade

Joshua Glover

7 papers receiving 459 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge

2017 267 citations Norbert Pardi, Anthony Secreto et al. Nature Communications profile →

Peers

Countries citing papers authored by Joshua Glover

Since Specialization

Citations

This map shows the geographic impact of Joshua Glover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua Glover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua Glover more than expected).

Fields of papers citing papers by Joshua Glover

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua Glover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua Glover. The network helps show where Joshua Glover may publish in the future.

Co-authorship network of co-authors of Joshua Glover

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua Glover. A scholar is included among the top collaborators of Joshua Glover based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua Glover. Joshua Glover is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	HIV-Resistant and HIV-Specific CAR-Modified CD4+ T Cells Mitigate HIV Disease Progression and Confer CD4+ T Cell Help In Vivo 2020 ·Molecular Therapy ·Colby R. Maldini, (unknown), Rachel S. Leibman, (unknown), Joshua Mills, Xiaochuan Shan, Joshua Glover, James L. Riley	26
2	Cytokines increase engraftment of human acute myeloid leukemia cells in immunocompromised mice but not engraftment of human myelodysplastic syndrome cells 2018 ·Haematologica ·Maria Krevvata, Xiaochuan Shan, (unknown), Cédric Dos Santos, (unknown), Anthony Secreto, Joshua Glover, Winifred Trotman, (unknown), Selene Nuñez-Cruz, Gerald Wertheim, Hyun-Jeong Ra, Elizabeth A. Griffiths, (unknown), Gwenn Danet-Desnoyers, Martin Carroll	28
3	Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor 2017 ·PLoS Pathogens ·Rachel S. Leibman, Max W. Richardson, Christoph T. Ellebrecht, Colby R. Maldini, Joshua Glover, Anthony Secreto, Irina Kulikovskaya, Simon F. Lacey, Sarah R. Akkina, Yanjie Yi, Farida Shaheen, Jianbin Wang, Keith Dufendach, Michael C. Holmes, Ronald G. Collman, Aimee Payne, James L. Riley	94
4	Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge breakdown → 2017 ·Nature Communications ·Norbert Pardi, Anthony Secreto, Xiaochuan Shan, Fotini Debonera, Joshua Glover, Yanjie Yi, Hiromi Muramatsu, Houping Ni, Barbara L. Mui, Ying K. Tam, Farida Shaheen, Ronald G. Collman, Katalin Karikó, Gwenn Danet-Desnoyers, Thomas D. Madden, Michael J. Hope, Drew Weissman	267
5	Improved Expansion and In Vivo Function of Patient T Cells by a Serum-free Medium 2017 ·Molecular Therapy — Methods & Clinical Development ·Andrew Medvec, (unknown), Hong Kong, (unknown), Joshua Glover, Angel Varela‐Rohena, James L. Riley	45
6	Anti-Leukemic Activity of Daratumumab in Acute Myeloid Leukemia Cells and Patient-Derived Xenografts 2014 ·Blood ·Cédric Dos Santos, Xiaochuan Shan, Chenghui Zhou, (unknown), Joshua Glover, (unknown), Parul Doshi, Kate Sasser, Gwenn Danet-Desnoyers	12
7	Improved Patient-Derived Xenograft Model for Acute Myeloid Leukemia 2014 ·Blood ·Xiaochuan Shan, Cédric Dos Santos, Chenghui Zhou, (unknown), Anthony Secreto, Joshua Glover, Winifred Trotman, Martin Carroll, Gwenn Danet-Desnoyers	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact